Flex Pharma (FLKS) Misses Q2 EPS by 10c

Flex Pharma (NASDAQ: FLKS) reported Q2 EPS of ($0.47), $0.10 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group